Journal
JOURNAL OF MEDICINAL CHEMISTRY
Volume 48, Issue 7, Pages 2258-2261Publisher
AMER CHEMICAL SOC
DOI: 10.1021/jm049090z
Keywords
-
Categories
Ask authors/readers for more resources
A series of fluoroglycosylated fluoroindolocarbazoles was examined with respect to their topoisomerase I activity, cytotoxicity, and selectivity. The lead clinical candidate from this series, BMS-250749, displays broad spectrum antitumor activity superior to CPT-11 against some preclinical xenograft models, including curative antitumor activity against Lewis lung carcinoma.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available